Riddhi Siddhi Gluco Biols Limited

As of June 30, 2026, Riddhi Siddhi Gluco Biols Limited carries a market capitalization of 5.35B, placing it among publicly traded companies globally. Its enterprise value stands at 5.35B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Riddhi Siddhi Gluco Biols Limited has 7.13M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 3.12 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 5.35B versus a market cap of 5.35B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 171.11M in revenue per employee across its workforce of 10.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Riddhi Siddhi Gluco Biols Limited recorded 66.06M in income tax expense. That works out to an effective tax rate of 31.12, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 212.25M, leaving -94.88M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Riddhi Siddhi Gluco Biols Limited's stock has gained approximately 16.86% over the past 52 weeks. The 50-day moving average sits at 740.76, while the 200-day moving average is 640.38.

Over the twelve months ended June 30, 2026, Riddhi Siddhi Gluco Biols Limited generated 1.71B in revenue and converted that into -94.88M in net income, yielding earnings per share of 21.65. EBITDA reached -146.91M, while operating income came in at -231.74M.

Over the twelve months ended June 30, 2026, Riddhi Siddhi Gluco Biols Limited posted a gross margin of 15.32, reflecting its pricing power and cost economics. The operating margin of -13.54 and net profit margin of -5.55 provide insight into operational efficiency.